269 related articles for article (PubMed ID: 18718067)
1. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
[TBL] [Abstract][Full Text] [Related]
2. [Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome].
Zhang YZ; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):281-4. PubMed ID: 16638197
[TBL] [Abstract][Full Text] [Related]
3. [In vitro biological characteristics of mesenchymal stem cells from patients with myelodysplastic syndrome and their support to hematopoiesis].
Zhang YZ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):839-42. PubMed ID: 16277854
[TBL] [Abstract][Full Text] [Related]
4. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
5. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
[TBL] [Abstract][Full Text] [Related]
6. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
8. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
9. [Osteoblasts from patients with myelodysplastic syndrome express multiple cytokines and support hematopoietic progenitor cell survival in vitro].
Chen WM; Chen ZX; Cen JN; He J; Jiao XL; Pan JL; Qiu QC; Dai L; Liu DD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):78-83. PubMed ID: 18315905
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
13. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
14. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow mesenchymal stem cells derived from patients with myelodysplastic syndrome possess immunosuppressive activity].
Zhang YZ; DA WM; Huang WR; Gao CJ; Guo B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):302-5. PubMed ID: 17493336
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
17. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
[TBL] [Abstract][Full Text] [Related]
18. Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro.
Calkoen FG; Vervat C; van Pel M; de Haas V; Vijfhuizen LS; Eising E; Kroes WG; 't Hoen PA; van den Heuvel-Eibrink MM; Egeler RM; van Tol MJ; Ball LM
Stem Cell Res; 2015 Mar; 14(2):198-210. PubMed ID: 25679997
[TBL] [Abstract][Full Text] [Related]
19. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases.
Zhao ZG; Liang Y; Li K; Li WM; Li QB; Chen ZC; Zou P
Stem Cells Dev; 2007 Aug; 16(4):637-48. PubMed ID: 17784837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
